A First Human Test of Anti-Aging Shots is Underway

For the first time, a scientist team gave an anti-aging injection to a real person. The injection uses a technique called cellular reprogramming. It’s meant to make old cells act young again. Think of it like a software update for your body’s cells. Billionaires like Jeff Bezos and Sam Altman, along with big drug companies like Eli Lilly, are betting big on this idea. Until now, it was only tested on mice and monkeys. But this new test could change everything. If it works, it might help treat age-related diseases by making cells healthier. The first patient got the shot in the eye to treat glaucoma. Doctors won’t say much about the person, but they’ll watch closely for six months. They’re checking if the treatment actually works and if it’s safe. No major side effects have been reported yet.The science behind this isn’t new. Back in 2007, a scientist named Shinya Yamanaka found a way to turn old cells into young ones using four special proteins. Now, researchers want to tweak this process. They don’t want to turn cells completely back to their newborn state. Instead, they want cells to act younger while still doing their normal jobs. Some companies are testing this in humans. One startup is starting with eye-related diseases because the eye is protected from side effects. Others are looking at liver and muscle cells to help with strength and energy as we age. But there’s a big risk: cancer. Two of the four proteins used in reprogramming can cause cells to grow out of control. In mouse tests, some developed tumors. To stay safe, this new trial uses only three proteins and a pill to turn the treatment on and off. Even with the risks, scientists see huge potential. If successful, this could be a game-changer for how we treat aging. But it’s still early days. Most experts agree we’re a long way from a real anti-aging drug.